Taysha Gene Therapies TSHA
NASDAQ TSHA
$4.63 -0.11 (-2.32%)
At close: Oct 2, 2026 · 4:00 PM EDT

Taysha Gene Therapies (TSHA) Change in Intangibles (2020 - 2026)

Updated

Taysha Gene Therapies (TSHA) reported Change in Intangibles of $3 million for Q1 2026, up 693.7% from $378,000 a year earlier.

Analysis

Taysha Gene Therapies (TSHA) Change in Intangibles (2020 - 2026) Analysis & Trends

For FY2023, Taysha Gene Therapies posted Change in Intangibles of $3.5 million, down 17.6% from FY2022.

  • Change in Intangibles has declined for three consecutive years, with a three-year compound annual growth rate of -27.0% (FY2020 to FY2023).
  • By year, Change in Intangibles came in at $4.25 million in FY2022 (-32.0%), $6.25 million in FY2021 (-30.6%) and $9 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Intangibless (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.28 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -437.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -2.34 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Taysha Gene Therapies 1.51 Bn 1.51 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 3.00 Mn
Mar 31, 2025 378,000.00
Mar 31, 2024 140,000.00
Sep 30, 2022 1.00 Mn
Jun 30, 2022 250,000.00
Mar 31, 2022 3.00 Mn
Dec 31, 2021 250,000.00
Sep 30, 2021 500,000.00
Dec 31, 2020 6.00 Mn
API Access

Taysha Gene Therapies Change in Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-intangibles&ticker=TSHA&period=max&api_key=YOUR_API_KEY